Related Experiment Videos
MR spectroscopy of the breast
1Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
Magnetic Resonance Imaging Clinics of North America
|November 1, 1994
Summary
Magnetic resonance spectroscopy (MRS) noninvasively measures biochemical changes in breast cancer. This technique aids in diagnosing disease, understanding tumor biology, and determining prognosis.
Area of Science:
- Biochemistry
- Medical Imaging
- Oncology
Background:
- Breast cancer arises from cellular biochemistry disruptions affecting metabolite flux and cell membranes.
- These biochemical alterations are key indicators of disease state.
Purpose of the Study:
- To highlight the role of MR spectroscopy in noninvasively assessing breast cancer biochemistry.
- To demonstrate how MR spectroscopy data complements MR imaging for diagnosis and prognosis.
Main Methods:
- Utilizing magnetic resonance (MR) spectroscopy to measure and monitor noninvasively biochemical alterations in breast cancer.
- Analyzing MR spectra to characterize metabolic pathways and biomolecular interactions within cells.
Main Results:
- MR spectroscopy provides complementary data to MR imaging, offering insights into cellular biochemistry.
- The biochemical information from MR spectra can differentiate between disease and non-disease states.
Conclusions:
- MR spectroscopy is a valuable tool for physicians, moving beyond its origins in physical chemistry.
- This technique enhances the understanding of tumor biology, aids in diagnosis, and helps determine prognosis for breast cancer patients.